TITLE

New Ways to Bring Tears to Patients' Eyes

AUTHOR(S)
Stephenson, Michelle
PUB. DATE
November 2011
SOURCE
Review of Ophthalmology;Nov2011, Vol. 18 Issue 11, p36
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article offers information on various dry-eye treatments under Phase II and III trials of the U.S. Food and Drug Administration (FDA). It states that the CF101 A3 adenosine receptor agonist from Can-Fite BioPharma Ltd. will be subjected to Phase III clinical trial to compare the efficiency of two doses with placebo. It says that sodium hyaluronate was shown to be efficient for dry eye treatment. Meanwhile, a Phase III trial for diquafosol will confirm the drug's safeness and efficiency.
ACCESSION #
67496273

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics